Latest Regulatory Clearance News

4DMedical lands a contract with pharma giant GSK, gains UKCA certification for its CT:VQ™ lung imaging technology, and joins the S&P/ASX 200, marking a significant step in its global expansion.

Advanced Innergy Holdings has formalised its $0.40 per share offer to acquire Matrix Composites via a scheme of arrangement, aiming to expand its subsea manufacturing footprint across the Asia-Pacific region.

Matrix Composites & Engineering has agreed to a full acquisition by Advanced Innergy Holdings at $0.40 per share, delivering shareholders a premium of up to 68% over recent trading prices. The deal, backed unanimously by Matrix’s board, awaits shareholder and court approval with completion targeted for July 2026.

PPK Group has inked a conditional deal to sell its near 40% interest in Craig International Ballistics to German defence firm Mehler for a headline price of A$27.45 million plus a potential earn-out. Completion is targeted by June 30, 2026, subject to regulatory and contractual conditions.

Multistack International has formalised the sale of nearly all its assets and liabilities to Hong Kong-based Willing Y Limited, marking a decisive end to its loss-making operations. The transaction hinges on shareholder and regulatory approvals, with completion targeted for June 30, 2026.

The Federal Court has approved the acquisition scheme for Insignia Financial by CC Capital Partners, setting the stage for a $4.80 per share cash payout and imminent ASX suspension.

Neurizon Therapeutics has secured an additional A$2.7 million through a placement addressing the shortfall from its entitlement offer, lifting total proceeds to approximately A$8.5 million. This fresh capital strengthens the biotech’s balance sheet and provides financial flexibility as it advances its lead ALS drug NUZ-001 through pivotal clinical stages.

BlinkLab has secured A$17.5 million through an oversubscribed placement to fuel regulatory trials and commercial launch of its AI-driven autism and ADHD diagnostic tools.

Genesis Minerals is set to acquire Magnetic Resources for approximately A$639 million, offering Magnetic shareholders a 25-35% premium. The deal unlocks synergies at the Lady Julie Gold Project, where an updated underground production target extends mine life to 14-19 years with improved economics.

Orthocell has secured approval for its Remplir™ nerve repair device to be used across 221 U.S. military and veterans hospitals, marking a major step in its U.S. commercial expansion. The approval follows clinical validation in conflict zones, positioning Orthocell to deepen penetration into defence healthcare.

National Storage REIT securityholders have overwhelmingly approved the Brookfield-GIC consortium's $2.86 per security cash acquisition, paving the way for a $6.7 billion transaction expected to complete in May 2026.

Blackstone Minerals has cleared a major regulatory hurdle with the lifting of a Cease and Desist Order at its Mankayan Copper-Gold Project, setting the stage for a pivotal Pre-Feasibility Study drilling campaign.